Tokyo and Kyoto, Japan From the Departments of Orthopedic Surgery and Physiology, Keio University School of Medicine; the Advanced Biomedical Engineering Research Unit and the Institute for Frontier Medical Sciences, Kyoto University; and the Department of Orthopedic Surgery, Murayama Medical Center, National Hospital Organization.
Plast Reconstr Surg. 2012 Oct;130(4):866-876. doi: 10.1097/PRS.0b013e318262f36e.
Despite numerous articles on the use of artificial nerve conduits, autologous nerve transplants remain the most effective for nerve repair. To improve this technique, the authors examined conduits containing gelatin hydrogel as a carrier enabling the sustained release of basic fibroblast growth factor (bFGF).
To confirm sustained bFGF release in vivo, nerve-guide tubes containing iodine-125-labeled bFGF with or without gelatin hydrogel were implanted under the skin of mice, and the remaining radioactivity was measured. Next, a 15-mm segment of the sciatic nerve was resected and repaired with autologous nerve (group 1), a tube with gelatin hydrogel and bFGF (group 2), a tube with bFGF alone (group 3), or a tube only (group 4). Histologic and functional analyses were performed for 16 weeks after surgery.
The radioactivity from iodine-125-labeled bFGF incorporated into gelatin hydrogel decreased more slowly than iodine-125-labeled bFGF alone. Four weeks after surgery, significantly more regenerating axons were detected in group 2 than in groups 3 and 4, but the axonal density in group 2 was lower than in group 1. Similarly, the animals in group 2 showed significantly better motor performance than those in groups 3 and 4, but worse than those in group 1. The animals in groups 1 and 2 showed significantly better sensory recovery than those in groups 3 and 4.
The nerve-guide tube containing gelatin hydrogel and bFGF promoted axonal regeneration after peripheral nerve injury, but not as well as autologous transplants. Understanding the limitations of this technique will facilitate its improvement for clinical applications.
尽管有许多关于使用人工神经导管的文章,但自体神经移植仍然是修复神经最有效的方法。为了改进这项技术,作者研究了含有明胶水凝胶作为载体的导管,使碱性成纤维细胞生长因子(bFGF)能够持续释放。
为了确认体内 bFGF 的持续释放,将含有碘-125 标记的 bFGF 的神经导管与或不与明胶水凝胶一起植入小鼠皮下,并测量剩余的放射性。接下来,切除 15mm 长的坐骨神经段,用自体神经(第 1 组)、含有明胶水凝胶和 bFGF 的导管(第 2 组)、仅含有 bFGF 的导管(第 3 组)或仅导管(第 4 组)修复。手术后 16 周进行组织学和功能分析。
碘-125 标记的 bFGF 掺入明胶水凝胶中的放射性下降速度比碘-125 标记的 bFGF 单独下降速度更慢。手术后 4 周,第 2 组再生轴突的数量明显多于第 3 组和第 4 组,但第 2 组的轴突密度低于第 1 组。同样,第 2 组的动物运动性能明显优于第 3 组和第 4 组,但不如第 1 组。第 1 组和第 2 组的动物感觉恢复明显优于第 3 组和第 4 组。
含有明胶水凝胶和 bFGF 的神经导管促进周围神经损伤后的轴突再生,但不如自体移植效果好。了解该技术的局限性将有助于其改进,以应用于临床。